Delivery Order SPE2DB24D1007-SPE2DB24FBZVW
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,709.07, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $3,920.01 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 23, 2025 with a completion date of June 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,745.24, is for the delivery of 4566295865 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This is a firm fixed-price Delivery Order contract with a completion date of November 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The $6,347.73 firm fixed-price delivery order has a completion date of July 18, 2024 and was awarded on July 17, 2024. The contract is not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a ceiling value of $3,453.16 and a completion date of June 11, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor for this...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA). The $29,422.64 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a performance period ending on March 8, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567694135 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical commodity, with a ceiling value of $7,126.90. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 26, 2025. The contract is not associated with a set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,673.75 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, with a performance period through March 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $3,261.66. The contract is a Firm Fixed Price Delivery Order with a period of performance extending to June 27, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML medical products. The contract has a ceiling value of $15,922.06 and an ultimate completion date of November 18, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...